Skip to content
Research Article Open access CC BY 4.0

Epidemiology and Management of Acquired Angioedema Due to C1 Inhibitor Deficiency

Mohammed Olaythah Alraddadi, Yousef Hussain J. Alharthi, Rayyan Fahad H. Altemani, Wejdan Mohammed S. Alshehri, Amal Nafea J. Alharbi, Raghad Saud A. Albalawi, Khawla Abdulrahman S. Alzahrani, Shuruq Mousa D. Albalawi, Sultan Suliman Q. Al-Ruwaili, Sultan Faraj Alruwaili, Mousa Amer M. Alshehri, Asma Saleh S. Alruwaili, Sarah Mohammad M. Ali, Ahmad Arafat A. Abualaz, Marah Saud Alenezi

Journal of Pharmaceutical Research International · pp. 107–113 · Published 14 Dec 2021

10.9734/jpri/2021/v33i57B34034

Abstract

AAE-C1-INH (acquired angioedema owing to C1-inhibitor (C1-INH) deficiency) is a dangerous illness that can lead to asphyxiation due to laryngeal edoema. Only around 1% to 2% of angioedema cases are classified as HAE or AAE, with HAE being 10 times more prevalent than AAE. The sole clinical distinction between HAE and AAE is the age at which symptoms appea, AAE-C1-INH is usually diagnosed after 40 years of age. There is no licensed therapy for AAE-C1-INH at this time. AAE-C1-INH attacks are treated with HAE-C1-INH medicines such plasma-derived C1-INH concentrate (pdC1-INH) and the bradykinin B2 receptor antagonist, icatibant. These on-demand medications are thought to be most helpful when provided early in the attack. However, there is a scarcity of published data on the efficacy and safety of AAE-C1-INH therapies.

Angioedema acquired angioedema due to c1 inhibitor deficiency non - pitting edema edema

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.